Eporgen Venture SpA announced on July the 23rd 2008 the appointment of Dr. Konstantinos EFTHYMIOPOULOS as President of the Company with immediate effect.The Board of Directors and the Shareholders give the warmest welcome to the new President.

Konstantinos (48) possess a unique profile of expertise in the Pharmaceutical and Biotechnology industry, built on an in-depth knowledge of the value chain and on 15 years of international experience covering all aspects of drug Discovery, Development, Registration and Launch. He worked in a wide range of therapeutic areas, including Dermatology, Rheumatology, Gastroenterology, Anti-infectives, CNS, Cardiovascular and Oncology.